Skip to content

Role of ayurveda in the management of urticaria(Sheetapitta)

Efficacy of Virechana Karma Followed by Vishaghna Mahakashaya Siddha Yoga Basti in the Management of Sheetapitta W.S.R. to Urticaria:An Open Labelled Randomized Standard Controlled Clinical Trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/081429
Enrollment
40
Registered
2025-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L500- Allergic urticaria

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Willing and able to participate in the study Patient having eruption alone with any 2 or more symptoms of sheetapitta mentioned in diagnostic criteria and having Chronicity of disease less than or equal to 2 years yogya for Virechana Karma and Basti Karma as per Ayurvedic Classics

Exclusion criteria

Exclusion criteria: Patients of age group less than 20 years and above 60 years Disease like uncontrolled Diabetes mellitus, hypertension, heart disease or other systemic illness Pregnent and lactating women Patients Ayogya for Virechana and Basti Karma Having chronicity more than 2 years

Design outcomes

Primary

MeasureTime frame
It is expected that trial protocol will provide relief in sign and symptoms of Sheetapitta(Urticaria) It may bring changes in the level of IgE, AEC, ESRTimepoint: Group-A 25-30 days Group-B 25-30 days

Secondary

MeasureTime frame
Improvement in Urticaria activity score UAS7Timepoint: Group-A 25-30 days Group-B 25-30 days

Countries

India

Contacts

Public ContactDr Neha G Tank

Institute of Teaching and Research in Ayurveda

neha@itra.edu.in9825391284

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026